{"id":"perisoxal","rwe":[{"pmid":"6489869","year":"1984","title":"[Effects of anti-inflammatory drugs on the lame walking reaction in adjuvant-induced edematous rats].","finding":"","journal":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica","studyType":"Clinical Study"},{"pmid":"7340954","year":"1981","title":"Isolation of perisoxal glucuronides and determination of enantiomeric ratios of d-and l-perisoxal metabolites excreted in rabbit urine.","finding":"","journal":"Chemical & pharmaceutical bulletin","studyType":"Clinical Study"},{"pmid":"7226293","year":"1980","title":"Analytical studies on isoxazoles. II A new fluorimetric determination of 5-phenyl-3-isoxazolecarboxylic acid and its application to the determination of perisoxal in plasma.","finding":"","journal":"Chemical & pharmaceutical bulletin","studyType":"Clinical Study"},{"pmid":"7448957","year":"1980","title":"Determination of perisoxal and its phenolic metabolites in rat, rabbit and human urine.","finding":"","journal":"Chemical & pharmaceutical bulletin","studyType":"Clinical Study"},{"pmid":"315279","year":"1979","title":"Absorption, excretion, distribution and metabolism of perisoxal in rats.","finding":"","journal":"Chemical & pharmaceutical bulletin","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"isoxal","offLabel":[],"synonyms":["isoxal","31252-S","perisoxal","perisoxal citrate"],"timeline":[],"approvals":[],"brandName":"Isoxal","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine Isoxal as a key that fits into a lock on a protein. When it binds, it can either turn the protein on or off, or change the way it works. This can help to treat a variety of diseases, but the exact way it works depends on the specific protein it targets.","oneSentence":"Isoxal works by binding to specific proteins or receptors in the body to produce a therapeutic effect.","technicalDetail":"Isoxal's mechanism of action is likely to involve reversible binding to a specific protein or receptor, altering its activity or expression to produce a therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2110","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PERISOXAL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:18:10.090889","biosimilars":[],"competitors":[],"genericName":"perisoxal","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"H0YBV6N85R","CHEBI":"CHEBI:135126","INN_ID":"3529","UMLSCUI":"C0070445","ChEMBL_ID":"CHEMBL2105453","KEGG_DRUG":"D01439","PUBCHEM_CID":"71109","SECONDARY_CAS_RN":"2139-25-5","MESH_SUPPLEMENTAL_RECORD_UI":"C021233"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1984 Aug","pmid":"6489869","title":"[Effects of anti-inflammatory drugs on the lame walking reaction in adjuvant-induced edematous rats].","journal":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica"},{"date":"1981 Dec","pmid":"7340954","title":"Isolation of perisoxal glucuronides and determination of enantiomeric ratios of d-and l-perisoxal metabolites excreted in rabbit urine.","journal":"Chemical & pharmaceutical bulletin"},{"date":"1980 Dec","pmid":"7226293","title":"Analytical studies on isoxazoles. II A new fluorimetric determination of 5-phenyl-3-isoxazolecarboxylic acid and its application to the determination of perisoxal in plasma.","journal":"Chemical & pharmaceutical bulletin"},{"date":"1980 Jul","pmid":"7448957","title":"Determination of perisoxal and its phenolic metabolites in rat, rabbit and human urine.","journal":"Chemical & pharmaceutical bulletin"},{"date":"1979 May","pmid":"315279","title":"Absorption, excretion, distribution and metabolism of perisoxal in rats.","journal":"Chemical & pharmaceutical bulletin"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Isoxal, also known as Perisoxal, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its mechanism of action and safety considerations. Further research is needed to fully understand Isoxal's properties and potential uses.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}